<DOC>
	<DOCNO>NCT00438477</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , lymphoscintigraphy use injection nipple near tumor , may help doctor find far disease spread . PURPOSE : This clinical trial study two different injection method compare well find sentinel lymph node lymphatic mapping sentinel lymph node biopsy patient invasive breast cancer .</brief_summary>
	<brief_title>Injection Methods Finding Sentinel Lymph Node During Lymphatic Mapping Sentinel Lymph Node Biopsy Patients With Invasive Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare subareolar injection peritumoral injection identify sentinel node breast lymphatic mapping patient invasive breast cancer . - Compare lymphatic drainage pattern use lymphoscintigraphy breast subareolar injection v peritumoral injection . OUTLINE : At least 2 day schedule surgery , patient receive technetium Tc 99m sulfur colloid peritumoral injection follow lymphoscintigraphy . Images obtain 30 minute 2 3 hour , provide drainage note . Patients receive technetium Tc 99m sulfur colloid subareolar injection follow another lymphoscintigraphy . At time surgery , patient receive isosulfan blue subareolar injection . A handheld gamma probe use locate sentinel node . If sentinel node identify , excise schedule breast surgery perform . If sentinel node identify , patient undergo schedule breast surgery . PROJECTED ACCRUAL : A total 100 patient accrue study within 12.5 month .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Technetium Tc 99m Sulfur Colloid</mesh_term>
	<criteria>1 . Patients must either pathologic , radiologic clinical evidence breast cancer invasion , suspicious invasion microinvasion . 2 . Patients candidate total mastectomy segmental mastectomy axillary dissection . 3 . Patients undergone neoadjuvant chemotherapy FNA confirm lymph node positive metastatic disease prior induction chemotherapy find grossly palpable disease ultrasound node negative time study entry . 4 . Patients must sign informed consent register procedure perform . 1 . A pregnancy test require preoperatively woman childbearing potential patient pregnant exclude study . 2 . Patients undergone neoadjuvant chemotherapy FNA confirm lymph node metastatic disease prior induction chemotherapy find grossly suspicious palpable disease ultrasound node positive time study entry . 3 . Patients know allergy isosulfan blue dye related compound .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>recurrent breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
</DOC>